Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAXF4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,150
Award facts
- Contract value 100% obligated
- $17,149.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,149.81 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-tablet units) under a firm fixed-price contract. The award, issued on May 23, 2025, with an ultimate completion date of May 27, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
RINVOQ ER (upadacitinib extended release) is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. This delivery order exemplifies the routine pharmaceutical procurement conducted through DLA's medical supply chain to support military healthcare programs and veteran services. AmerisourceBergen's substantial prime vendor agreement with DLA positions the company as a critical distributor for federal medical supplies, enabling rapid fulfillment of pharmaceutical requirements across military health system facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FAXF4?
SPE2DB25FAXF4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 23, 2025.
How much is contract SPE2DB25FAXF4 worth?
The government has obligated $17,150 on SPE2DB25FAXF4.
Is contract SPE2DB25FAXF4 an order under another contract?
Yes. SPE2DB25FAXF4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAXF4 competed?
The extent of competition for SPE2DB25FAXF4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award